1-Methyl-4-phenethyl-piperazine

ID: ALA435234

PubChem CID: 12730761

Max Phase: Preclinical

Molecular Formula: C13H20N2

Molecular Weight: 204.32

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(CCc2ccccc2)CC1

Standard InChI:  InChI=1S/C13H20N2/c1-14-9-11-15(12-10-14)8-7-13-5-3-2-4-6-13/h2-6H,7-12H2,1H3

Standard InChI Key:  DBGWPOIRMDKCHA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.0833    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1167    0.8208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6833    0.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833    0.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833    1.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1833    1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1875    0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9833    1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5833    1.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7167    0.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8833    1.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8833    0.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4708    1.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4833    0.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7750    1.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  6  1  0
  3  1  1  0
  4  1  1  0
  5  1  1  0
  6  5  1  0
  7  4  1  0
  8  3  1  0
  9  8  1  0
 10  2  1  0
 11  9  2  0
 12  9  1  0
 13 11  1  0
 14 12  2  0
 15 14  1  0
  2  7  1  0
 15 13  2  0
M  END

Alternative Forms

Associated Targets(Human)

DRD2 Tclin Dopamine receptor (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 204.32Molecular Weight (Monoisotopic): 204.1626AlogP: 1.48#Rotatable Bonds: 3
Polar Surface Area: 6.48Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.33CX LogP: 2.05CX LogD: 1.08
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.74Np Likeness Score: -1.09

References

1. Glennon RA, Salley JJ, Steinsland OS, Nelson S..  (1981)  Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists.,  24  (6): [PMID:7252977] [10.1021/jm00138a007]

Source